ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 52 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,427,000 | -86.0% | 256,340 | -88.4% | 1.06% | -84.8% |
| Q2 2017 | $38,764,000 | -14.8% | 2,216,351 | -14.8% | 6.94% | -23.2% |
| Q1 2017 | $45,524,000 | +3.6% | 2,601,351 | 0.0% | 9.04% | +0.1% |
| Q4 2016 | $43,963,000 | +3.0% | 2,601,351 | 0.0% | 9.03% | -17.0% |
| Q3 2016 | $42,688,000 | +33.7% | 2,601,351 | +23.3% | 10.89% | +19.1% |
| Q2 2016 | $31,932,000 | +4.7% | 2,109,099 | 0.0% | 9.14% | -16.4% |
| Q1 2016 | $30,498,000 | -25.1% | 2,109,099 | +46.7% | 10.94% | -35.9% |
| Q4 2015 | $40,705,000 | +119.1% | 1,437,335 | +29.5% | 17.08% | +132.4% |
| Q3 2015 | $18,581,000 | -8.3% | 1,110,000 | +43.7% | 7.35% | -6.9% |
| Q2 2015 | $20,258,000 | +90.3% | 772,600 | +26.9% | 7.90% | +68.6% |
| Q1 2015 | $10,645,000 | +258.8% | 608,650 | +256.3% | 4.68% | +228.1% |
| Q4 2014 | $2,967,000 | – | 170,816 | – | 1.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |